Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.340
+0.090 (2.77%)
At close: Jan 30, 2026, 4:00 PM EST
3.360
+0.020 (0.60%)
After-hours: Jan 30, 2026, 7:55 PM EST
Rezolute Market Cap
Rezolute has a market cap or net worth of $309.71 million as of January 30, 2026. Its market cap has increased by 14.96% in one year.
Market Cap
309.71M
Enterprise Value
158.97M
1-Year Change
14.96%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $309.71M, an increase of 85.46%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 309.70M | 41.54% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 320.07M |
| Immuneering | 314.46M |
| Immix Biopharma | 313.54M |
| XOMA Royalty | 309.21M |
| Atea Pharmaceuticals | 305.48M |
| Larimar Therapeutics | 305.13M |
| Neurogene | 292.60M |
| Aardvark Therapeutics | 290.67M |